XBI : Analysis & Opinions

  1. Celgene Winding Up for 2017 Breakout (CELG, IBB)

    Celgene is attracting steady buying interest after three successful tests at deep support and could enter a powerful 2017 ...
  2. These Charts Suggest Now Is the Time to Buy Biotech (SRPT, XBI)

    The pullback toward key support levels is suggesting that 2017 could be the year that biotech investors have been hoping ...
  3. Charts Suggest 2017 Will Be the Year of Biotech (XBI, IBB)

    The charts of these biotech ETFs suggest that now is the time to buy.
  4. Two Big Biotechs Flash Bearish Signals (CELG, GILD)

    Biotech funds are trading near rally highs, but two popular blue chip components are struggling, a foretelling weakness that ...
  5. How Financial Advisors Measure Capital Market Expectations (WFC, BLK)

    Capital market expectations directly influence how a financial advisor allocates asset classes in a portfolio, resulting ...
  6. Active Traders Turn Bullish on Biotech (IBB, XBI)

    The recent price activity of two key ETFs suggests that the biotech sector is poised for a comeback.
  7. Celgene Set to Squeeze Short Sellers (CELG, IBB)

    Celgene has broken out of a year-long descending triangle top and could enter a major short squeeze.
  8. Biotech Bottom Calls After Big Bounce (IBB, XBI)

    Biotech funds have bounced sharply after testing downtrend lows, setting off a wave of bottom calls.
  9. IBB & XBI: Should You Short the Biotech Industry? (IBB, XBI)

    Explore an analysis of the biotech industry, and learn why XBI and IBB may be short candidates based on Jim Chanos' short ...
  10. 3 Cases When Not to Place Tight Stop-Loss Orders (IBB, XBI)

    Learn about using stop-loss orders for exchange-traded funds. Discover the circumstances when using a tight stop-loss order ...
  11. Downside Ahead For Biotech Stocks?

    Since the August 24 and January 20 lows in the stock market, Biotechnology stocks have been massive under-performers. Currently ...
  12. Biotech Funds Selling Off at Resistance (IBB, XBI)

    Biotech funds should reward well-timed short sales after weekly buy cycles work through the system.
  13. Biotech Stocks: Are They Back?

    The bearish trends over the past year have started to reverse themselves which has benefted the biotech industry
  14. Breaking Down XBI: 3 Components That Are Most Attractive

    Explore stocks from the SPDR S&P Biotech ETF, with consideration given to fundamentals and the status of drug candidates ...
  15. 4 Markets in Which Vanguard Doesn't Offer the Cheapest ETF

    Discover which ETFs in non-Vanguard sectors offer the lowest expense ratios, and learn why you may still want to purchase ...
  16. Health Care ETFs to Date: 2016 Performance Review (IHI, XBI)

    Find out how the health care sector has been performing in 2016, and which health care ETFs have been the best and worst ...
  17. Curb Your Enthusiasm With the Biotech Bounce (IBB, XBI)

    The biotech bounce should mark a time sensitive event, ahead of a decline to much deeper lows.
  18. (XBI, FBT, IBB) 3 Bond ETFs in the Biotech Sector

    Learn about the top biotechnology ETFs, such as the SPDR S&P Biotech ETF, the First Trust NYSE Arca Biotech ETF and the ...
  19. The Top 5 Biotechnology ETFs for 2016 (XBI, IBB)

    Read analyses of the top biotech ETFs for 2016, and learn about the characteristics of the funds that may be poised to rebound.
  20. The Best Sectors To Sell Short in 2016 (PG, T)

    Three groups of stocks and sectors should underperform in 2016, generating profits from selling high and buying low.
  21. XBI: SPDR S&P Biotech ETF

    Discover the investment management style of SPDR S&P Biotech ETF, and learn which investors can benefit from the fund's ...
  22. Weakness In Biotech Will Likely Continue (XBI, IBB)

    You can breathe easy with your biotech holdings--assuming you aren't counting on them to make you rich.
  23. Should You Avoid Biotech Stocks Right Now? (IBB, BXI) (LABD, IBB)

    Biotech has been on fire but investors are starting to get burned.
  24. Top ETF Performers YTD - They'll Surprise You (XIV, XBI)

    The top performing ETFs of 2015 may surprise you. Here they are, and the outlook for them going forward.
  25. Top 3 Biotech ETFs (XBI, IBB)

    Learn about three popular ETFs in the biotechnology sector, how they differ, and which ones may be appropriate for long term ...
  26. A Quick Guide To Healthcare ETFs

    The healthcare industry offers a broad variety of sector ETFs but it’s difficult to avoid exposure to pharmaceuticals and ...
  27. The Biggest Biotech Companies

    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies ...
  28. Buyer Beware In Biotech ETFs

    The biotech sector has been flat this year, and the five biotech ETFs have been hit and miss - mainly miss.